CENTER FOR ADVANCED TECHNOLOGY
Mission
The State University of New York at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) supports university-industry collaboration in research, education and technology transfer, with a strong focus on helping New York State-based businesses gain a technological edge on their competition. Operating under the auspices of the New York State Office of Science, Technology and Academic Research (NYSTAR), the UB CAT is fueling continued growth in some of the most promising technologies of tomorrow and in some of the most important sectors of the state's economy. The UB CAT operates within the New York State Center of Excellence in Bioinformatics & Life Sciences (CoE) under the leadership of Dr. Bruce A. Holm, Executive Director of the CoE and Senior Vice Provost at UB and Dr. Esther Takeuchi, Professor, Department of Chemical and Biological Engineering and Electrical Engineering, UB School of Engineering and Applied Sciences.
The UB CAT, one of fifteen such Centers for Advanced Technology located across the state, focuses on biomedical and bioengineering research that can lead to development of useful products with commercial potential. By accelerating science and technology transfer, the UB CAT fosters the creation of new biotech start-up companies and helps existing biomedical businesses expand through new or improved product lines. The lines of communication between translational researchers and those involved in commercialization of life sciences products and services are opened and supported through the UB CAT program on behalf of improving the health and well-being of the population and driving economic development.
Areas of Expertise
The UB CAT will consider for funding and supporting any biomedical technology or bioengineering device with application in the medical field that can improve the health and well-being of the population.
Areas of expertise for the UB CAT include:
- bioengineering
- bioimaging
- bioinformatics
- cardiovascular disease
- disease modeling
- epidemiology
- genomics
- high performance computing
- immunotherapy
- infectious disease
- neurodegenerative disease
- oncology
- ontology
- oral biology
- structural biology
- pharmacology
- proteomics
Our expertise is leveraged with a particular focus on creating products and services in the following life sciences industry sectors: biotechnology, biomedical informatics, diagnostics, medical devices, pharmaceuticals, and research & development.
Project Funding & Support
Projects are selected for CAT funding based on scientific and technical merit and potential economic impact. Additionally, projects require a cash contribution from a New York-based company. According to NYSTAR regulations, corporate sponsorship is a prerequisite for funding. Funding--up to $150,000--can be awarded to a project with matching corporate sponsor funds at a 5:1ratio (i.e. 5 corporate dollars for every NYSTAR dollar). A typical CAT grant is in the $20,000 to $50,000 range. More information on funding and matching fund guidelines is provided within the CAT application. Hand-in-hand with funding, the UB CAT also provides R&D resources and business development assistance, workforce development programming, and other outreach and networking opportunities. Visit www.bioinformatics.buffalo.edu for an updated programming and events schedule.
Application
A request for proposals has been issued for the 2008-2009 funding year. If you are a researcher or entrepreneur who needs assistance with research and development, related business development, and project funding, please download the *UB CAT Project Application. Project applications are due by May 31, 2008. Note that all projects are subject to State University of New York intellectual property policies.
Applications are reviewed on an annual basis typically for funding starting July 1st or after, although the program may at times accept submissions on a rolling basis. Projects are reviewed by the UB CAT Industrial Advisory Board in the selection process.
For more information, contact:
Marnie LaVigne, Ph.D.
UB CAT Director of Business Development
at (716) 881-8904
or lavigne2@buffalo.edu
News
Reception to Honor UB's Inventors, Entrepreneurs
05/04/2008 - BUFFALO, N.Y. -- The University at Buffalo and its Office of Science, Technology Transfer and Economic Outreach (STOR) will recognize the research and commercialization achievements of faculty members at the annual Inventors and Entrepreneurs Reception to be held from 4-6 p.m. May 5 in The Buffalo Club, 388 Delaware Ave...[Read On]
Study Describes Mechanism Linking Alcohol with Risk of Breast Cancer
04/30/2008 - BUFFALO, N.Y. -- The known association of alcohol consumption with an increased risk of breast cancer has been linked by researchers at the University at Buffalo to a process that causes genes that promote normal cell growth to produce proteins that precipitate unregulated cell growth, an action known as hypermethylation...[Read On...]
Visit the News Archive
Events
May 6 - Dr. Austin Clean Room Program
Don’t miss the opportunity to hear one of the world’s foremost Cleanroom and Contamination Control Experts. Dr. Austin has published six textbooks on clean rooms and personally authored each of the clean room standards adopted by ISO. This program will take place from 2-6pm Roswell Park Cancer Institute, Center for Genetics & Pharmacology, Zebro Room, 701 Ellicott Street, Buffalo, NY. Register at www.thepartnership.org/events. See flyer for more information. 
May 8 – HWI Seminar Series
Please join Dr. Michael Rossman from Purdue University for a presentation on “Symmetry and asymmetry in the control of viral assembly, maturation and infection”. Program begins at 2:30pm with a reception to follow. Series is held at the Hauptman-Woodward Institute 700 Ellicott Street, Buffalo, NY 14203.
To view the complete list of events and event details, please visit our Events page
To receive periodic News & Events emails from the COE, please join our mailing list!
